2021
-
Study Identifies Lung Cancer Areas of Improvement Across Asia-Pacific Region
Lung cancer prevention and treatment remains a challenge across the Asia-Pacific region, and each country has areas where they could improve, according to a study presented during the Day 2 […]
-
Several Studies Assess the Fallout From the COVID-19 Pandemic in Patients With Lung Cancer
The COVID-19 pandemic has undoubtedly altered patient care as countries have locked down to prevent spread of the virus and shifted resources to accommodate surging caseloads. It has also taken […]
-
Redefining Good Quality Resections in NSCLC
Curative-intent resections for NSCLC often fail. Approximately 20% to 40% of patients with lung cancer who undergo curative-intent resection, experience a relapse, and die within 4 years. One key factor […]
-
Examining Value and Access in Lung Cancer Care, From Screening to Treatment
Appropriate and swift diagnosis and treatment are crucial for patients with lung cancer but can be elusive for many due to cost, healthcare disparities, and other barriers. Factors such as […]
-
IASLC Award Recognizes Importance of Cancer Care Teamwork
The IASLC awarded four cancer care teams from around the globe with one of the association’s most prestigious award—the IASLC Cancer Care Team Award (CCTA). The winning teams were announced […]
-
More Options Needed After First-Line Chemoimmunotherapy in Lung Cancer
As an increasing number of immunotherapy treatments find their way into the front-line treatment of solid tumors, including lung cancer, clinicians are often faced with a lack of options when […]
-
Post-Traumatic Stress Symptoms Found in About 25% of Patients with Cancer During COVID
Protecting patients with cancer is an important component of public health measures to address the COVID-19 epidemic, especially as one new study has found that about one-quarter of people living […]
-
Immunohistochemistry’s Important Role in Diagnosis of Thoracic Cancers Explained in a New Atlas
The latest in the series of diagnostic Atlases has been published by the IASLC and its Pathology Committee. Following the highly successful editions on ALK, EGFR, ROS1 and PD-L1, this […]
-
Program Trains Patient Research Advocates to be STARS
What does it take to become a star in any setting? Passion, knowledge, and drive. When it comes to understanding the science of lung cancer, sometimes the experts are the […]
-
Enhancing Your WCLC Experience with Twitter
Even those who are unfamiliar with social media platforms can find Twitter to be an easy way to discuss research and collaborate with colleagues. If you do not already have […]
View ILCN Archives
Provider Resources